SPOK
VENTE TOTALE: 8 320 titres (~93 869,57 $ US)
- Insiders
- COURNOYER CHRISTINE
- Total bought
- —
- Total sold
- $93,870
- Last activity
- 2026-08-10
- Last synced
-
2026-08-16 09:56:14
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Neutral signal Scored 2026-08-13
SPOK shows solid financial foundations — minimal debt, strong cash flow, and improving margins — paired with a genuine earnings catalyst (Q2 2026 beat, record adjusted EBITDA, hospital recognition), but the catalyst…
The first sentence of the analysis written for SPOK on 2026-08-13 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 78.8% | 79.3% | 58.9% | 56.0% | 49.2% | |
| Ebit Margin | 15.3% | 14.6% | 16.1% | 0.7% | -19.2% | |
| Ebitda Margin | 17.8% | 17.6% | 19.3% | 3.4% | -11.9% | |
| Operating Profit Margin | 14.1% | 13.8% | 15.7% | 5.6% | -8.5% | |
| Pretax Profit Margin | 15.3% | 14.6% | 16.1% | 0.7% | -19.2% | |
| Continuous Operations Profit Margin | 11.4% | 10.9% | 11.3% | 16.2% | -15.6% | |
| Net Profit Margin | 11.4% | 10.9% | 11.3% | 16.2% | -15.6% | |
| Bottom Line Profit Margin | 11.4% | 10.9% | 11.3% | 16.2% | -15.6% | |
| Current Ratio | 1.179 | 1.257 | 1.331 | 1.311 | 1.710 | |
| Quick Ratio | 1.179 | 1.257 | 1.331 | 1.182 | 1.589 | |
| Solvency Ratio | 0.323 | 0.307 | 0.315 | 0.351 | -0.158 | |
| Cash Ratio | 0.515 | 0.598 | 0.666 | 0.669 | 0.811 | |
| Price To Earnings Ratio | 17.130 | 21.689 | 19.595 | 7.378 | -8.184 | |
| Price To Earnings Growth Ratio | 4.225 | -3.427 | -0.680 | -0.037 | 0.161 | |
| Forward Price To Earnings Growth Ratio | 4.225 | -3.427 | -0.680 | -0.037 | 0.161 | |
| Price To Earnings Diluted Ratio | 17.587 | 21.986 | 20.104 | 7.514 | -8.184 | |
| Price To Earnings Diluted Growth Ratio | 6.419 | -4.232 | -0.685 | -0.038 | 0.161 | |
| Price To Book Ratio | 1.857 | 2.099 | 1.886 | 0.936 | 1.042 | |
| Price To Sales Ratio | 1.945 | 2.360 | 2.222 | 1.198 | 1.274 | |
| Price To Free Cash Flow Ratio | 10.787 | 12.634 | 13.567 | 60.118 | -24.913 | |
| Price To Operating Cash Flow Ratio | 9.389 | 11.233 | 11.797 | 24.956 | 22.721 | |
| Debt To Assets Ratio | 0.034 | 0.040 | 0.049 | 0.064 | 0.070 | |
| Debt To Equity Ratio | 0.047 | 0.057 | 0.068 | 0.091 | 0.100 | |
| Debt To Capital Ratio | 0.045 | 0.054 | 0.063 | 0.084 | 0.091 | |
| Long Term Debt To Capital Ratio | 0.028 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Financial Leverage Ratio | 1.408 | 1.403 | 1.390 | 1.421 | 1.429 | |
| Working Capital Turnover Ratio | 13.119 | 9.691 | 8.560 | 4.835 | 2.829 | |
| Operating Cash Flow Ratio | 0.589 | 0.593 | 0.545 | 0.121 | 0.145 | |
| Operating Cash Flow Sales Ratio | 0.207 | 0.210 | 0.188 | 0.048 | 0.056 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.870 | 0.889 | 0.870 | 0.415 | -0.912 | |
| Debt Service Coverage Ratio | 7.216 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Operating Cash Flow Coverage Ratio | 10.818 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 4.172 | 3.297 | 2.362 | 0.411 | 0.461 | |
| Capital Expenditure Coverage Ratio | 7.714 | 9.013 | 7.663 | 1.710 | 0.523 | |
| Dividend Paid And Capex Coverage Ratio | 0.933 | 0.977 | 0.901 | 0.224 | 0.315 | |
| Dividend Payout Ratio | 1.716 | 1.763 | 1.637 | 1.144 | -0.452 | |
| Enterprise Value Multiple | 10.191 | 12.574 | 10.737 | 30.881 | -9.105 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 78.8% | ▼-0.5% | ▲14.4% |
| Ebit Margin | 15.3% | ▲0.8% | ▲9.8% |
| Ebitda Margin | 17.8% | ▲0.2% | ▲8.6% |
| Operating Profit Margin | 14.1% | ▲0.3% | ▲6.0% |
| Pretax Profit Margin | 15.3% | ▲0.8% | ▲9.8% |
| Continuous Operations Profit Margin | 11.4% | ▲0.5% | ▲4.5% |
| Net Profit Margin | 11.4% | ▲0.5% | ▲4.5% |
| Bottom Line Profit Margin | 11.4% | ▲0.5% | ▲4.5% |
| Current Ratio | 1.179 | ▼-0.078 | ▼-0.179 |
| Quick Ratio | 1.179 | ▼-0.078 | ▼-0.129 |
| Solvency Ratio | 0.323 | ▲0.017 | ▲0.096 |
| Cash Ratio | 0.515 | ▼-0.083 | ▼-0.137 |
| Price To Earnings Ratio | 17.130 | ▼-4.559 | ▲5.608 |
| Price To Earnings Growth Ratio | 4.225 | ▲7.652 | ▲4.177 |
| Forward Price To Earnings Growth Ratio | 4.225 | ▲7.652 | ▲4.177 |
| Price To Earnings Diluted Ratio | 17.587 | ▼-4.400 | ▲5.785 |
| Price To Earnings Diluted Growth Ratio | 6.419 | ▲10.652 | ▲6.094 |
| Price To Book Ratio | 1.857 | ▼-0.243 | ▲0.293 |
| Price To Sales Ratio | 1.946 | ▼-0.415 | ▲0.146 |
| Price To Free Cash Flow Ratio | 10.787 | ▼-1.847 | ▼-3.651 |
| Price To Operating Cash Flow Ratio | 9.389 | ▼-1.844 | ▼-6.630 |
| Debt To Assets Ratio | 0.034 | ▼-0.007 | ▼-0.018 |
| Debt To Equity Ratio | 0.047 | ▼-0.009 | ▼-0.025 |
| Debt To Capital Ratio | 0.045 | ▼-0.008 | ▼-0.022 |
| Long Term Debt To Capital Ratio | 0.028 | ▲0.028 | ▲0.023 |
| Financial Leverage Ratio | 1.408 | ▲0.005 | ▼-0.002 |
| Working Capital Turnover Ratio | 13.119 | ▲3.428 | ▲5.313 |
| Operating Cash Flow Ratio | 0.590 | ▼-0.004 | ▲0.191 |
| Operating Cash Flow Sales Ratio | 0.207 | ▼-0.003 | ▲0.065 |
| Free Cash Flow Operating Cash Flow Ratio | 0.870 | ▼-0.019 | ▲0.444 |
| Debt Service Coverage Ratio | 7.216 | ▲7.216 | ▲5.773 |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Short Term Operating Cash Flow Coverage Ratio | 10.818 | ▲10.818 | ▲8.654 |
| Operating Cash Flow Coverage Ratio | 4.172 | ▲0.875 | ▲2.031 |
| Capital Expenditure Coverage Ratio | 7.714 | ▼-1.299 | ▲2.389 |
| Dividend Paid And Capex Coverage Ratio | 0.933 | ▼-0.044 | ▲0.263 |
| Dividend Payout Ratio | 1.716 | ▼-0.046 | ▲0.555 |
| Enterprise Value Multiple | 10.191 | ▼-2.383 | ▼-0.865 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $271.8M | $324.9M | $308.9M | $161.1M | $181.0M | |
| Enterprise value | $253.5M | $304.5M | $288.0M | $141.1M | $153.7M | |
| EV / Sales | 1.81x | 2.21x | 2.07x | 1.05x | 1.08x | |
| EV / Op. cash flow | 8.76x | 10.53x | 11.00x | 21.85x | 19.30x | |
| EV / Free cash flow | 10.06x | 11.84x | 12.65x | 52.64x | -21.16x | |
| EV / EBITDA | 10.19x | 12.57x | 10.74x | 30.88x | -9.11x | |
| Net debt / EBITDA | -0.74x | -0.84x | -0.78x | -4.39x | 1.62x | |
| Current ratio | 1.18x | 1.26x | 1.33x | 1.31x | 1.71x | |
| Income quality | 1.82x | 1.93x | 1.67x | 0.29x | -0.36x | |
| Graham number | $11 | $11 | $12 | $15 | — | |
| Graham net-net | -$1 | -$1 | -$1 | -$1 | $0 | |
| Tax burden | 74.1% | 74.7% | 70.2% | 2192.2% | 81.2% | |
| Interest burden | 100.0% | 99.8% | 100.0% | 100.0% | 100.0% | |
| Working capital | $8.8M | $12.5M | $15.9M | $16.6M | $39.1M | |
| Invested capital | $120.2M | $125.9M | $132.9M | $137.9M | $160.8M | |
| Return on assets | 7.7% | 6.9% | 6.9% | 8.9% | -8.9% | |
| Operating ROA | 9.3% | 8.5% | 9.2% | 3.1% | -4.6% | |
| Return on tangible assets | 14.9% | 12.7% | 12.2% | 15.0% | -14.9% | |
| Return on equity | 10.8% | 9.7% | 9.6% | 12.7% | -12.8% | |
| Return on invested capital | 9.1% | 8.3% | 8.3% | 3.9% | -4.9% | |
| Return on capital employed | 12.6% | 11.3% | 12.1% | 4.0% | -6.2% | |
| Earnings yield | 5.8% | 4.6% | 5.1% | 13.6% | -12.3% | |
| Free cash flow yield | 9.3% | 7.9% | 7.4% | 1.7% | -4.0% | |
| Capex / Op. cash flow | 13.0% | 11.1% | 13.0% | 58.5% | 191.2% | |
| Capex / Depreciation | 109.4% | 77.4% | 76.0% | 105.7% | 145.8% | |
| Capex / Sales | 2.7% | 2.3% | 2.5% | 2.8% | 10.7% | |
| SG&A / Sales | 36.4% | 35.7% | 35.6% | 40.2% | 45.0% | |
| R&D / Sales | 8.7% | 8.4% | 7.6% | 10.1% | 12.6% | |
| Stock comp / Sales | 3.6% | 3.6% | 2.9% | 2.8% | 5.1% | |
| Intangibles / Total assets | 48.1% | 45.7% | 43.6% | 40.6% | 40.0% | |
| Days sales outstanding | 59d | 58d | 61d | 73d | 69d | |
| Days payables outstanding | 49d | 72d | 38d | 36d | 27d | |
| Operating cycle | 59d | 58d | 61d | 115d | 103d | |
| Cash conversion cycle | 10d | -14d | 23d | 79d | 76d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▼-16.3%EV / Sales ▼-18.0%EV / EBITDA ▼-19.0%EV / Op. cash flow ▼-1.773Earnings yield ▲+0.012Graham number ▼-0.179
Profitability
Return on equity ▲+0.012Return on assets ▲+0.008Return on invested capital ▲+0.009Return on capital employed ▲+0.013Operating ROA ▲+0.008Income quality ▼-0.110Tax burden ▼-0.006
Efficiency
Days sales outstanding ▲+0.957Days payables outstanding ▼-23.210Operating cycle ▲+0.957Cash conversion cycle ▲+24.167Capex / Sales ▲+0.004R&D / Sales ▲+0.003
Balance-sheet strength
Current ratio ▼-0.078Net debt / EBITDA ▲+0.104Working capital ▼-3748000.000Invested capital ▼-5749000.000Intangibles / Total assets ▲+0.024
Change over 5 years
Valuation
Market cap ▲+50.1%EV / Sales ▲+67.7%EV / EBITDA ▲+211.9%EV / Op. cash flow ▼-10.540Earnings yield ▲+0.181
Profitability
Return on equity ▲+0.236Return on assets ▲+0.166Return on invested capital ▲+0.141Return on capital employed ▲+0.188Operating ROA ▲+0.139Income quality ▲+2.182Tax burden ▼-0.071
Efficiency
Days sales outstanding ▼-9.931Days payables outstanding ▲+22.342Operating cycle ▼-43.473Cash conversion cycle ▼-65.815Capex / Sales ▼-0.080R&D / Sales ▼-0.039
Balance-sheet strength
Current ratio ▼-0.531Net debt / EBITDA ▼-2.354Working capital ▼-30280000.000Invested capital ▼-40647000.000Intangibles / Total assets ▲+0.082
Employee count
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-08-06 Spok-Powered Hospitals Recognized on 2026-2027 U.S. News & World Report''s Best Hospitals Honor Roll PLANO, Texas--(BUSINESS WIRE)--Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and a global leader in healthcare communications, today reported that 18 of the 20 adult hospitals featured on the 2026-2027 U.S. News & World Report Best Hospitals Honor Roll use Spok technology to enhance care coordination and support exceptional patient care. For over a decade, the majority of Honor Roll hospitals have consistently leveraged Spok solutions to streamline workflows an.
- 2026-07-29 Spok Q2 Earnings Call Highlights Spok NASDAQ: SPOK reported second-quarter 2026 results marked by higher software bookings, record adjusted EBITDA and continued capital returns to stockholders, while management modestly lowered its full-year revenue outlook amid longer customer sales cycles and demand for shorter contract terms.
- 2026-07-29 Spok Holdings, Inc. (SPOK) Q2 2026 Earnings Call Transcript Spok Holdings, Inc. (SPOK) Q2 2026 Earnings Call Transcript
- 2026-07-29 Spok Holdings (SPOK) Q2 Earnings and Revenues Surpass Estimates Spok Holdings (SPOK) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.22 per share a year ago.
- 2026-07-29 Spok Reports Second Quarter 2026 Results PLANO, Texas--(BUSINESS WIRE)--Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced results for the second quarter ended June 30, 2026. In addition, the Company''s Board of Directors declared a regular quarterly dividend of $0.3125 per share, payable on September 9, 2026, to stockholders of record on August 19, 2026. Recent Highlights: Adjusted EBITDA totaled $9.1 million in the second quarter of 2026, up 22.1% from the prior year period. Second-quart.
- 2026-06-24 Spok Announces Sale of Spectrum Licenses to Sensus PLANO, Texas--(BUSINESS WIRE)--Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced the entry into an agreement to sell certain narrowband spectrum licenses in its two-way paging inventory to Sensus USA, a designer and manufacturer of metering and automatic meter-reading products catering to municipal and industrial markets worldwide. The purchase price is $8 million, with a portion of the consideration deferred until existing Spok users have been mi.